IP Library Granted Patent US 11,072,783
Granted Patent B2
US 11,072,783 · App. 15/760,055 · Granted Jul 27, 2021

Compositions and methods comprising the use of exiguobacterium acetylicum and bacillus coagluans alpha-glucanotransferase enzymes

Inventor: Slavko Kralj (Oegstgeest, NL)
Assignee: DUPONT NUTRITION BIOSCIENCES APS
C12N9/1051A23L2/52A23L33/10C12N9/1074C12P19/00C12Y204/01025A23V2002/00A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,072,783
App. No.
15/760,055
Granted
Jul 27, 2021
Kind
B2
Abstract

An isolated and/or purified α-glucanotransferase from Exiguobacterium Acetylicum , recombinantly engineered variants thereof, active fragments thereof, synthetic nucleic acids encoding the α-glucanotransferase and variants thereof, host cells comprising the synthetic nucleic acids, and compositions comprising the α-glucanotransferase are provided. Methods of using the compositions include the manufacture of oligosaccharides.

Claims (12)

1. A composition comprising at least: (i) an isolated GH70 subfamily 4 α-glucanotransferase comprising an amino acid sequence that is at least 95% identical to amino acids 31-731 of SEQ ID NO:2, and (ii) a glucooligosaccharide with α-(1→4) and α-(1→6) glycosidic linkages.

2. The composition of claim 1 , wherein the α-glucanotransferase comprises an amino acid sequence that is at least 98% identical to amino acids 31-731 of SEQ ID NO:2.

3. The composition of claim 1 , wherein the α-glucanotransferase comprises an amino acid sequence that is at least 99% identical to amino acids 31-731 of SEQ ID NO:2.

4. The composition of claim 1 , wherein the α-glucanotransferase comprises an amino acid sequence that is at least 99.5% identical to amino acids 31-731 of SEQ ID NO:2.

5. The composition of claim 1 , wherein the α-glucanotransferase comprises amino acids 31-731 of SEQ ID NO:2.

6. The composition of claim 1 , wherein the composition is in a lyophilized powder form, an encapsulated form, a coated form, a granulated form, or a liquid formulation.

7. The composition of claim 1 , further comprising a diluent.

8. A method of producing saccharide products, said method comprising contacting the α-glucanotransferase according to claim 1 with a substrate comprising a maltooligosaccharide or maltodextrin under conditions of pH 3-10 and 30-70° C. to produce at least one glucooligosaccharide with α-(1→4) and α-(1→6) glycosidic linkages.

9. The method of claim 8 , wherein the substrate comprises malto-tetraose, malto-pentaose, malto-hexaose, or maltoheptaose.

10. The method of claim 8 , wherein the substrate is comprised in a beverage or food, wherein said glucooligosaccharide with α-(1→4) and α-(1→6) glycosidic linkages is produced in the beverage or food in situ.

11. The method of claim 10 , wherein the substrate is comprised in said beverage.

12. The method of claim 10 , wherein the substrate is comprised in said food.

Assignments (1)
CHANGE OF NAME Recorded Feb 6, 2024
From: DUPONT NUTRITION BIOSCIENCES APS
To: INTERNATIONAL N&H DENMARK APS
Reel/Frame 066494/0814 →